ABSTRACT:
The objective of the present study was to prepare transdermal patches of amiodarone using sustained release polymers enriched with permeation enhancer utilizing solvent evaporation method. The casting solution was prepared using hydroxypropylmethyl cellulose, ethylcelluose and Eudragit RS100 as the polymeric matrix. DMSO was used as the permeation enhancer and glycerol was used as the plasticizer. Optimization of the formulation was done using 23 factorial design followed by multiple regression analysis and surface response analysis of the release response to generate the polynomial equations to select the best combination of polymers. Hydroxypropylethyl cellulose and ethylcellulose were found to be most suitable copolymeric combination.
Cite this article:
Ragni Kumari, Virendra Kumar Sharma. Optimization of the Formulation of Transdermal patches of Amiodarone. Research Journal of Pharmacy and Technology 2023; 16(8):3739-2. doi: 10.52711/0974-360X.2023.00617
Cite(Electronic):
Ragni Kumari, Virendra Kumar Sharma. Optimization of the Formulation of Transdermal patches of Amiodarone. Research Journal of Pharmacy and Technology 2023; 16(8):3739-2. doi: 10.52711/0974-360X.2023.00617 Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-8-37
REFERENCES:
1. Amiodarone. Available from https://go.drugbank.com/drugs/DB01118; assessed on 04/09/2021.
2. Siddoway LA. 2003. Amiodarone: Guidelines for use and monitoring. American Academy of Family Physicians. 2003; 68(11): 2189-2197. Available from https://www.aafp.org/afp/2003/1201/p2189.html.
3. Amiodarone. Available from https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018972s051lbl.pdf; assessed 04/09/2021.
4. Jaworski K, Walecka I, Rudnicka L, Gnatowski M, Kosior DA. Cutaneous Adverse reactions of Amiodarone. Medical Science Monitor. 2014; 20, 2369-2372. Available from http://www.medscimonit.com/abstract/index/idArt/890881.
5. Jatav VS, Saggu JS, Sharma AK, Mehra GR, Sharma A, Jat RK. Design, Formulation and in vitro Drug Release from Transdermal Patches containing Nebivolol Hydrochloride as Model Drug. Asian Journal of Pharmaceutical Research. 2012; 2(4): 136-141
6. Vasavi G, Naga Haritha P, Chandrashekhar B. Formulation Development and In vitro Evaluation of Transdermal Patches of Tramadol HCl. Asian Journal of Research in Pharmaceutical Sciences. 2018; 8(3): 123-129. DOI: 10.5958/2231-5659.2018.00021.8
7. Madhu Latha AVS, Naga Ravikiran T, Suresh Kumar JN. Formulation, Optimization and Evaluation of Glibenclamide Transdermal Patches by using chitosan Polymer. Asian Journal of Pharmacy and Technology. 2019; 9(1): 01-07. DOI: 10.5958/2231-5713.2019.00001.1
8. Jadhav SB, Koshti AR, Bari MM, Barhate SD. Formulation optimization and Evaluation of Transdermal patch of losartan potassium containing DMSO as permeation enhancer. Asian Journal of Pharmacy and Technology. 2019; 9(3): 220-227. DOI: 10.5958/2231-5713.2019.00037.0
9. Jatav VS, Saggu JS, Sharma AK, Sharma A, Jat RK. Evaluation of Transdermal Patches of Nebivolol Hydrochloride. Research Journal of Pharmaceutical Dosage Forms and Technology. 2012; 4(5): 272-277.
10. Das A, Ghosh S, Das S, Dey BK, Ghosh TK. Formulation and In Vitro Evaluation of Transdermal Patches of Metformin Hydrochloride Using Hydrophilic and Hydrophobic Polymer Complex. Research Journal of Pharmacy and Technology. 2011; 4(4): 561-565.
11. Wu P-C, Tsai P-J, Lin S-C, Huang Y-B. Formulation Optimization of Arecoline Patches. The Scientific World Journal. 2014; 945168. http://dx.doi.org/10.1155/2014/945168
12. Bankhele SC, Harale RB, Rao MRP, Dhoka MV. Thermoreversible In-Situ Ophthalmic Gelling System of Levofloxacin Hemihydrate: Formulation and Optimization by Factorial Design. Asian Journal of Pharmaceutical Research. 2012; 2(3): 100-106.
13. Darharwal SJ, Thakur VD, Shrivastava S, Sahu BP. Designing and Optimization of medicated chewing gum of Ambroxol HCl by using 32 Factorial design. Asian Journal of Pharmaceutical Research. 2013; 3(3): 118-120.
14. Dalvi SD, Nanda RK, Chitlange SS. Full Factorial Design for Optimization, Development, Validation of RPHPLC Method and Stability-Indicating Method for Tamsulosin and Dutastaride. Asian Journal of Research in Chemistry. 2017; 10(4): 504-512. DOI: 10.5958/0974-4150.2017.00082.7
15. Mandlik SK, Nandare DS, Joshi MM, Chudiwal PD, Jain KS. Statistical Optimization of Orodispersible Tablets Containing Telmisartan Using Factorial Design and Response Surface Methodology. Research Journal of Pharmacy and Technology. 2009; 2(3): 548-551.
16. Nandare DS, Mandlik SK, Khiste SK, Mohite YD. Formulation and Optimization of Mouth dissolving tablets of Olanzapine by using 32 Factorial Design. Research Journal of Pharmacy and Technology. 2011; 4(8): 1265-1268.
17. Mahajan NM, Zode GH, Mahapatra DK, Thakre S, Dumore N, Gangane PS. Formulation development and evaluation of transdermal patch of piroxicam for treating dysmenorrhoea. Journal of Applied Pharmaceutical Sciences. 2018; 8(11), 35-40. Available online at http://www.japsonline.com
18. Pandey T, Kumar A, Sharma R. Effect of essential oils as penetration enhancers for ibuprofen loaded transdermal gel formulations. Journal of Pharmacology and Biomedicine. 2021; 5(2), 268-271.
19. Braun-Falco O, Korting HC. Normal pH value of human skin. Hautarzt. 1986; 37(3), 126-129